Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
49.71
+1.46 (3.03%)
At close: Jun 26, 2026, 4:00 PM EDT
50.03
+0.32 (0.64%)
After-hours: Jun 26, 2026, 6:29 PM EDT
Structure Therapeutics Employees
Structure Therapeutics had 220 employees as of December 31, 2025. The number of employees increased by 57 or 34.97% compared to the previous year.
Employees
220
Change (1Y)
57
Growth (1Y)
34.97%
Revenue / Employee
n/a
Profits / Employee
-$731,060
Market Cap
3.53B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 220 | 57 | 34.97% |
| Dec 31, 2024 | 163 | 70 | 75.27% |
| Dec 31, 2023 | 93 | 25 | 36.76% |
| Dec 31, 2022 | 68 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Crinetics Pharmaceuticals | 594 |
| Beam Therapeutics | 522 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Alumis | 227 |
| uniQure | 221 |
| Catalyst Pharmaceuticals | 182 |
GPCR News
- 10 days ago - Structure Therapeutics Transcript: AGM 2026 - Transcripts
- 17 days ago - Structure Therapeutics price target lowered to $70 from $100 at H.C. Wainwright - TheFly
- 19 days ago - Structure Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 22 days ago - Structure's experimental obesity pill shows no signs of liver injury - Reuters
- 22 days ago - Structure Therapeutics announces ACCESS trial data published in Nature Medicine - TheFly
- 22 days ago - Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity - GlobeNewsWire
- 23 days ago - Structure Therapeutics Slides: Corporate presentation - Filings
- 24 days ago - Structure Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts